18 Einträge gefunden

1. Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - A retrospective analysis of a real world registry

   1. Müller, Volkmar
   2. Hein, Alexander
   3. Hartkopf, Andreas D
   4. Fasching, Peter A
   5. Kolberg, Hans-Christian
   6. Hadji, Peyman
   7. Tesch, Hans

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients - Data from the Real-World Registry PRAEGNANT

   1. Engler, Tobias
   2. Fasching, Peter A
   3. Lüftner, Diana
   4. Hartkopf, Andreas D
   5. Müller, Volkmar
   6. Kolberg, Hans-Christian
   7. Hadji, Peyman

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status

   1. Hein, Alexander
   2. Hartkopf, Andreas D
   3. Emons, Julius
   4. Lux, Michael P
   5. Volz, Bernhard
   6. Taran, Florin-Andrei
   7. Overkamp, Friedrich

   2021 - Forschungsinformationssystem des UKE
4. Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany"

   1. Schneeweiss, Andreas
   2. Ettl, Johannes
   3. Lüftner, Diana
   4. Beckmann, Matthias W
   5. Belleville, Erik
   6. Fasching, Peter A
   7. Fehm, Tanja N

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
5. International Consensus Conference for Advanced Breast Cancer, Lisbon 2019:ABC5 Consensus - Assessment by a German Group of Experts

   1. Thomssen, Christoph
   2. Lüftner, Diana
   3. Untch, Michael
   4. Haidinger, Renate
   5. Würstlein, Rachel
   6. Harbeck, Nadia
   7. Augustin, Doris

   2020 - Forschungsinformationssystem des UKE
6. Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab

   1. Michel, Laura L
   2. Hartkopf, Andreas D
   3. Fasching, Peter A
   4. Kolberg, Hans-Christian
   5. Hadji, Peyman
   6. Tesch, Hans
   7. Häberle, Lothar

   2020 - Forschungsinformationssystem des UKE
7. Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany

   1. Schneeweiss, Andreas
   2. Ettl, Johannes
   3. Lüftner, Diana
   4. Beckmann, Matthias W
   5. Belleville, Erik
   6. Fasching, Peter A
   7. Fehm, Tanja N

   2020 - Forschungsinformationssystem des UKE
8. Update Breast Cancer 2020 Part 1 - Early Breast Cancer:Consolidation of Knowledge About Known Therapies

   1. Schneeweiss, Andreas
   2. Hartkopf, Andreas D
   3. Müller, Volkmar
   4. Wöckel, Achim
   5. Lux, Michael P
   6. Janni, Wolfgang
   7. Ettl, Johannes

   2020 - Forschungsinformationssystem des UKE
9. Update Breast Cancer 2020 Part 2 - Advanced Breast Cancer:New Treatments and Implementation of Therapies with Companion Diagnostics

   1. Lüftner, Diana
   2. Schneeweiss, Andreas
   3. Hartkopf, Andreas D
   4. Müller, Volkmar
   5. Wöckel, Achim
   6. Janni, Wolfgang
   7. Ettl, Johannes

   2020 - Forschungsinformationssystem des UKE
10. Treatment Landscape and Prognosis After Treatment with Trastuzumab Emtansine

    1. Laakmann, Elena
    2. Emons, Julius
    3. Taran, Florin-Andrei
    4. Janni, Wolfgang
    5. Uhrig, Sabrina
    6. Overkamp, Friedrich
    7. Kolberg, Hans-Christian

    2020 - Forschungsinformationssystem des UKE
11. ABC5 International Consensus Conference on Advanced Breast Cancer, Lisbon, 16 November 2019:Commentary by the German panel of experts on the ABC5 voting results

    1. Untch, Michael
    2. Würstlein, Rachel
    3. Lüftner, Diana
    4. Haidinger, Renate
    5. Fasching, Peter A
    6. Augustin, Doris
    7. Briest, Susanne

    2020 - Forschungsinformationssystem des UKE
12. Update Breast Cancer 2020 Part 4 - Advanced Breast Cancer

    1. Tesch, Hans
    2. Müller, Volkmar
    3. Wöckel, Achim
    4. Ettl, Johannes
    5. Belleville, Erik
    6. Schütz, Florian
    7. Hartkopf, Andreas

    2020 - Forschungsinformationssystem des UKE
13. Update Breast Cancer 2020 Part 3 - Early Breast Cancer

    1. Huober, Jens
    2. Schneeweiss, Andreas
    3. Hartkopf, Andreas D
    4. Müller, Volkmar
    5. Lux, Michael P
    6. Janni, Wolfgang
    7. Ettl, Johannes

    2020 - Forschungsinformationssystem des UKE
14. ABC4 Consensus: Assessment by a German Group of Experts

    1. Harbeck, Nadia
    2. Lüftner, Diana
    3. Marschner, Norbert
    4. Untch, Michael
    5. Augustin, Doris
    6. Briest, Susanne
    7. Ettl, Johannes

    2018 - Forschungsinformationssystem des UKE
15. 4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017: ABC4 Consensus: Assessment by a Panel of German Experts

    1. Untch, Michael
    2. Würstlein, Rachel
    3. Marschner, Norbert
    4. Lüftner, Diana
    5. Augustin, Doris
    6. Briest, Susanne
    7. Ettl, Johannes

    2018 - Forschungsinformationssystem des UKE
16. Update Breast Cancer 2017 - Implementation of Novel Therapies

    1. Lux, Michael P
    2. Janni, Wolfgang
    3. Hartkopf, Andreas D
    4. Nabieva, Naiba
    5. Taran, Florin-Andrei
    6. Overkamp, Friedrich
    7. Kolberg, Hans-Christian

    2017 - Forschungsinformationssystem des UKE
17. Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry

    1. Wallwiener, Markus
    2. Heindl, Felix
    3. Brucker, Sara Y
    4. Taran, Florin-Andrei
    5. Hartkopf, Andreas
    6. Overkamp, Friedrich
    7. Kolberg, Hans-Christian

    2017 - Forschungsinformationssystem des UKE
18. Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patients

    1. Hein, Alexander
    2. Gass, Paul
    3. Walter, Christina Barbara
    4. Taran, Florin-Andrei
    5. Hartkopf, Andreas
    6. Overkamp, Friedrich
    7. Kolberg, Hans-Christian

    2016 - Forschungsinformationssystem des UKE